RSNA 2013 

Abstract Archives of the RSNA, 2013


LL-GIE-TH10B

Categorization of Other Malignancy Using LI-RADS v2013.1

Education Exhibits

Presented on December 5, 2013
Presented as part of LL-GIS-THB: Gastrointestinal - Thursday Posters and Exhibits (12:45pm - 1:15pm)

Participants

Amol Shah BS, Presenter: Nothing to Disclose
Masahiro Tanabe MD, Abstract Co-Author: Nothing to Disclose
Eduardo Almeida Cunha Costa MD, Abstract Co-Author: Nothing to Disclose
Abdullah Turki Alturki MD, MBBS, Abstract Co-Author: Nothing to Disclose
Kevin Amir Zand MD, Abstract Co-Author: Nothing to Disclose
Elhamy Rafat Heba BMBCh, Abstract Co-Author: Nothing to Disclose
Marilia Paes Fortes Diniz Ferreira MD, Abstract Co-Author: Nothing to Disclose
Claude B. Sirlin MD, Abstract Co-Author: Research Grant, Bayer AG Research Grant, General Electric Company Research Grant, Bracco Group Contract, Isis Pharmaceuticals, Inc Contract, Pfizer Inc Speakers Bureau, Bayer AG Consultant, Bayer AG Medical Advisory Board, Bayer AG Consultant, Merck & Co, Inc Medical Advisory Board, General Electric Company Consultant, sanofi-aventis Group Consultant, Synageva BioPharma Corporation Contract, Profil Consultant, Takeda Pharmaceutical Company Limited Contract, Siemens AG

PURPOSE/AIM

The purpose of this exhibit is to: Understand the concept, definition, reporting, and management of other malignancy. Review examples of other malignancy in the liver. Review clinical and imaging features suggestive of non-HCC malignancy.  

CONTENT ORGANIZATION

Introduction to LI-RADS: LI-RADS is an ACR-endorsed system of standardized terminology and criteria to interpret and report imaging examinations of the liver. LI-RADS assigns an ordinal score (1 to 5) to liver observations indicating likelihood of HCC. Overview of other malignancy: concept, definition, reporting, management. Clinical and imaging features of HCC and common non-HCC malignancies in the liver. Sample CT/MR images and schematics of HCC as well as common non-HCC malignancies.  

SUMMARY

The teaching points of this exhibit are: Examples of common non-HCC malignancies include: - Cholangiocellular carcinoma - Metastasis - Lymphoma - Post-transplant lymphoproliferative disorder Differentiation between HCC and non-HCC malignancies is important as the management and prognosis differ.  

Cite This Abstract

Shah, A, Tanabe, M, Costa, E, Alturki, A, Zand, K, Heba, E, Ferreira, M, Sirlin, C, Categorization of Other Malignancy Using LI-RADS v2013.1.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13020496.html